Medscape July 23, 2021
By Linda Carroll

(Reuters Health) – Chemotherapy patients who receive remote 24-hour monitoring may have better quality of life and better control of symptoms compared to those who receive standard care, a new study suggests.

In an analysis of data from 829 adult patients who had been randomly assigned to receive the 24-hour-monitoring or standard care at their cancer center through multiple cycles of chemotherapy, researchers found that for the intervention group, symptom burden remained at pre-chemotherapy levels, while controls reported an increase from cycle one onwards, according to the report published in The BMJ.

The intervention group participants were tracked with the Advanced Symptom Management System (ASyMS), a mobile based, remote patient monitoring system that provides real time, 24-hour monitoring and management...

Today's Sponsors

SalesSparx
Canton & Company
Oscar

Today's Sponsors

HLTH
ZeOmega

Today's Sponsor

Crossover Health

 
Topics: Digital Health, Health IT, Home, Patient / Consumer, Provider, Survey / Study, Technology, Telehealth, Trends
Remote patient monitoring use is on the rise, but reimbursement needs to catch up
Dr Elizabeth Kwo on the Expanding Use of Remote Patient Monitoring
Implementing remote patient monitoring the right way
Mayo's COVID-19 remote patient monitoring program reports strong tech engagement, study finds
Study highlights development of remote patient monitoring program during COVID-19 pandemic